Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
FRIENDSWOOD, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publicat
Castle Biosciences, Inc. (CSTL) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:01am, Thursday, 19'th Feb 2026
Castle Biosciences (CSTL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:36am, Monday, 09'th Feb 2026
Castle Biosciences (CSTL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026
07:00am, Thursday, 05'th Feb 2026
FRIENDSWOOD, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will
Allspring Emerging Growth Fund Q4 2025 Performance Review
02:24pm, Wednesday, 04'th Feb 2026
Allspring Emerging Growth Fund Q4 2025 Performance Review
Wasatch Micro Cap Fund Q4 2025 Performance Review
08:35am, Wednesday, 04'th Feb 2026
Leading individual contributors to the Fund's relative performance included Axogen, Inc., a holding within the health-care equipment industry. A provider of prepared food items such as meatballs and p
Derek Maetzold Sells 4,017 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
05:22am, Saturday, 24'th Jan 2026
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) insider Derek Maetzold sold 4,017 shares of the stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an averag
Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice
01:01pm, Friday, 23'rd Jan 2026
Does Castle Biosciences, Inc. (CSTL) have what it takes to be a top stock pick for momentum investors? Let's find out.
26,996 Shares in Castle Biosciences, Inc. $CSTL Acquired by Campbell & CO Investment Adviser LLC
03:51am, Thursday, 22'nd Jan 2026
Campbell and CO Investment Adviser LLC bought a new stake in shares of Castle Biosciences, Inc. (NASDAQ: CSTL) in the third quarter, according to its most recent filing with the Securities and Exchang
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
04:00pm, Sunday, 11'th Jan 2026
2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ®
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Analysts
01:30am, Wednesday, 07'th Jan 2026
Shares of Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, Market
Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus
11:21am, Monday, 29'th Dec 2025
Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.
What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'
09:56am, Wednesday, 24'th Dec 2025
Castle Biosciences (CSTL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it t
Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month High After Analyst Upgrade
01:16am, Tuesday, 23'rd Dec 2025
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) shares hit a new 52-week high during trading on Monday after Canaccord Genuity Group raised their price target on the stock from $37.00 to $50
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $20,380.36 in Stock
05:18am, Monday, 22'nd Dec 2025
Castle Biosciences, Inc. (NASDAQ: CSTL - Get Free Report) insider Derek Maetzold sold 509 shares of the business's stock in a transaction that occurred on Wednesday, December 17th. The stock was sold
